Clostridium difficile infection increases mortality risk in lung transplant recipients

Journal of Heart and Lung Transplantation

Volumn 32, Issue 10, 2013, Pages 1020-1026

  Lee, Janet T ^a   Kelly, Rosemary F ^b   Hertz, Marshall I ^b   Dunitz, Jordan M ^b   Shumway, Sara J ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Clostridium difficile infection; colitis; lung transplantation; mortality; transplant infection

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGED; ARTICLE; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; DATA BASE; DEATH; FEMALE; GRAFT RECIPIENT; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LENGTH OF STAY; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEPSIS; TOTAL COLON RESECTION; TOXIC MEGACOLON;

CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; LUNG TRANSPLANTATION; MORTALITY; TRANSPLANT INFECTION;

ADOLESCENT; ADULT; AGED; CHILD; CLOSTRIDIUM DIFFICILE; COHORT STUDIES; CYSTIC FIBROSIS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; LENGTH OF STAY; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION; YOUNG ADULT;

EID: 84884356500     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2013.06.012     Document Type: Article

References (39)

1. L.C. McDonald, M. Owings, and D.B. Jernigan Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003 Emerg Infect Dis 12 2006 409 415
2. M.D. Redelings, F. Sorvillo, and L. Mascola Increase in Clostridium difficile-related mortality rates, United States, 1999-2004 Emerg Infect Dis 13 2007 1417 1419
3. F. Burckhardt, A. Friedrich, D. Beier, and T. Eckmanns Clostridium difficile surveillance trends, Saxony, Germany Emerg Infect Dis 14 2008 691 692
4. C.P. Kelly, and J.T. LaMont Clostridium difficile: more difficult than ever N Engl J Med 359 2008 1932 1940
5. M.P. Bauer, D.W. Notermans, and B.H. van Benthem Clostridium difficile infection in Europe: a hospital-based survey Lancet 377 2011 63
6. B.A. Miller, L.F. Chen, D.J. Sexton, and D.J. Anderson Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals Infect Control Hosp Epidemiol 32 2011 387 390
7. V.G. Loo, L. Poirier, and M.A. Miller A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality N Engl J Med 353 2005 2442 2449
8. L.C. McDonald, G.E. Killgore, and R.C. Thompson An epidemic, toxin gene-variant strain of Clostridium difficile N Engl J Med 353 2005 2433 2441
9. C.A. Muto, M. Pokrywka, and K. Shutt A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoro-quinolone use Infect Control Hosp Epidemiol 26 2005 273 280
10. J. Pepin, L. Valiquette, and B. Cossette Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec CMAJ 173 2005 1037 1042
11. S. Khanna, D.S. Pardi, and S.L. Aronson The epidemiology of community-acquired Clostridium difficile infection: a population-based study Am J Gastroenterol 107 2012 89 95
12. J. Freeman, M.P. Bauer, and S.D. Baines The changing epidemiology of Clostridium difficile infections Clin Microbio Rev 23 2010 529 549
13. A.L. Vecchio, and G.M. Zacur Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options Curr Opin Gastroenterol 28 2012 1 9
14. A. Goorhuis, D. Bakker, and J. Corver Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078 Clin Infect Dis 47 2008 1162 1170
15. S. Khanna, and D.S. Pardi Clostridium difficile infection: new insights into management Mayo Clin Proc 87 2012 1106 1117
16. S. Dial, K. Alrasadi, C. Manoukian, A. Huang, and D. Menzies Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies CMAJ 171 2004 33 38
17. L.D. Bobo, E.R. Dubberke, and M. Kollef Clostridium difficile in the ICU: the struggle continues Chest 140 2011 1643 1653
18. D.L. Raines, and F.A. Lopez Clostridium difficile infection in non-HIV-immunocompromised patients and in HIV-infected patients Curr Gastroenterol Rep 13 2011 344e50
19. A.C. Gellad, B.D. Alexander, and B.C. Liu Severity of Clostridium difficile-associated diarrhea in solid organ transplant patients Transpl Infect Dis 9 2007 276 280
20. R.M. Dallal, B.G. Harbrecht, and A.J. Boujoukas Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications Ann Surg 235 2002 363 372
21. D. Neofytos, K. Kobayashi, and C.D. Alonso Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients Transpl Infect Dis 15 2012 134 141
22. C. Theunissen, C. Knoop, and C. Nonhoff Clostridium difficile colitis in cystic fibrosis patients with and without lung transplantation Transpl Infect Dis 10 2008 240 244
23. M. Boutros, M. Al-Shaibi, and G. Chan Clostridium difficile colitis: increasing incidence, risk factors, and outcomes in solid organ transplant recipients Transplantation 93 2012 1051 1057
24. C. Pant, M.P. Anderson, J.A. O'Connor, C.M. Marshall, A. Deshpande, and T.J. Sferra Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database Transpl Infect Dis 14 2012 540 547
25. C.C. Gunderson, M.R. Gupta, and F. Lopz Clostridium difficile colitis in lung transplantation Transpl Infect Dis 10 2008 245 251
26. I. Stelzmueller, H. Goegele, and M. Biebl Clostridium difficile colitis in solid organ transplantation - a single-center experience Dig Dis Sci 52 2007 3231 3236
27. S.H. Cohen, D.N. Gerding, and S. Johnson Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Infect Control Hosp Epidemiol 31 2010 431 455
28. K.W. Garey, S. Sethi, Y. Yadav, and H.L. DuPont Meta-analysis to assess risk factors for recurrent Clostridium difficile infection J Hosp Infect 70 2008 298 304
29. Lucado J, Gould C, Elixhauser A. Clostridium difficile infections (CDI) in hospital stays. Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality. Statistical brief #124. http://www.hcupus.ahrq. gov/reports/statbriefs/sb124.pdf. Accessed March 13, 2013.
30. M. Ali, A.N. Ananthakrishnan, S. Ahmad, N. Kumar, G. Kumar, and K. Saeian Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis Liver Transpl 18 2012 972 978
31. N. Daneman, T.A. Stukel, X. Ma, M. Vermeulen, and A. Guttmann Reduction in Clostridium difficile infection rates after mandatory hospital public reporting: findings from a longitudinal cohort study in Canada PLoS Med 9 2012 e1001268
32. D.R. Gardiner, T. Rosenberg, J. Zaharatos, D. Franco, and D.D. Ho A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A Vaccine 27 2009 3598 3604
33. H. Wang, X. Sun, and Y. Zhang A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection Infect Immun 80 2012 2678 2688
34. J. Steele, J. Sponseller, D. Schmidt, O. Cohen, and S. Tzipori Hyperimmune bovine colostrum for treatment of GI infections: a review and update on Clostridium difficile Hum Vaccin Immunother 9 2013 [Epub ahead of print]
35. M.J. Mayer, A. Narbad, and M.J. Gasson Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin J Bacteriol 190 2008 6734 6740
36. V. Ramesh, J.A. Fralich, and R.D. Rolfe Prevention of Clostridium difficile-induced ileocecitis with bacteriophage Anaerobe 5 1999 269 278
37. E. Meader, M.J. Mayer, and M.J. Gasson Bacteriophage treatment significantly reduces viable Clostridium difficile and prevents toxin production in an in vitro model system Anaerobe 16 2010 549 554
38. M. Hell, C. Bernhofer, P. Stalzer, J.M. Kern, and E. Claassen Probiotics in Clostridium difficile infection; reviewing the need for multistrain probiotic Benef Microbes 4 2013 39 51
39. J.W. Lancaster, and S.J. Matthews Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections Clin Ther 34 2012 1 13